JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iitsuka, Y.
Right arrow Articles by Hatano, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iitsuka, Y.
Right arrow Articles by Hatano, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 34, 24401-24407, August 20, 1999


An Enhancer Element for Expression of the Ncx (Enx, Hox11L1) Gene in Neural Crest-derived Cells*

Yoshinori IitsukaDagger §, Hironori ShimizuDagger , Myeng M. KangDagger , Kazushi SasagawaDagger , Souei Sekiya§, Takeshi TokuhisaDagger , and Masahiko HatanoDagger

From the Dagger  Department of Developmental Genetics, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan and the § Department of Obstetrics and Gynecology, Chiba University School of Medicine, Chiba 260-8670, Japan

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The murine Ncx (Enx, Hox11L1) gene is specifically expressed in a neuronal subset of neural crest-derived tissues. In attempts to elucidate the regulatory DNA element of the tissue-specific expression, we sequenced the 5'-flanking region of the Ncx gene. The transcriptional initiation site was determined at 297 nucleotides (-297) upstream from the ATG start codon (+1). A retinoic acid response element was located on the region between -1163 and -1150. Transient transfection assays with the 5'-flanking sequences fused to the luciferase gene showed that the region between -1387 and -1368 was crucial for the tissue-specific enhancer activity. Furthermore, nuclear proteins extracted from neural crest-derived cells such as murine and human neuroblastoma cells bind to the DNA region between -1387 and -1368. This DNA element was also conserved in the 5'-flanking region of the human NCX gene. Our observations strongly suggest that the DNA element (between -1387 and -1368) contributes to tissue-specific expression of the Ncx gene in murine and human species.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The mammalian homeobox (Hox) genes encode proteins containing a conserved 60-amino acid sequence (homeodomain) originally identified in Drosophila (1). In humans and mice, many of the Hox genes are clustered on four different chromosomes (HoxA, -B, -C, and -D), and each cluster retains a linear arrangement of the gene that is similar to its Drosophila counterpart. Expression of each Hox gene in the cluster is strictly regulated temporally and spatially during embryogenesis, and the gene located on the more 3' side of the cluster is expressed in the more anterior part of mouse embryo. Those clustered Hox genes play an important role in specification of position along axes in the developing embryo (1). In addition to clustered Hox genes, some Hox genes do not locate in those four cluster regions. Expression of the orphan Hox genes is also tightly regulated temporally and spatially during embryogenesis.

The murine Ncx/Enx/Hox11L1 gene (2, 3), a member of the Hox11 gene family (4-7) that locates outside Hox gene clusters (8), is expressed specifically in neural crest-derived tissues such as dorsal root ganglia, cranial ganglia (V, IX, and X), sympathetic ganglia, adrenal medulla, and enteric ganglia (9, 10). Neural crest cells arise from the dorsal part of neural tube and migrate along a number of defined routes to various tissues from embryonic day 9.5. These neural crest cells mainly differentiate into neuronal cells in the peripheral nervous system, melanocytes, and cephalic mesenchymal cells such as smooth muscle and cartilage (11). Since the Ncx mRNA has not been detected in the cell lineage of melanocytes and mesenchymal cells (9), it is apparently specifically expressed in a neuronal subset of neural crest-derived tissues. The regulatory mechanisms of expression have remained to be identified.

Deregulated expression of the HOX genes can be oncogenic in humans (5, 12, 13). Mice with mutations in Hox genes also have a variety of congenital anomalies resembling human genetic diseases. For example, mice deficient for the Ncx gene developed megacolon with the hyperinnervation of enteric neurons in the narrow segment of megacolon (10, 14). This phenotype resembles the human disease known as neuronal intestinal dysplasia. Therefore, a detailed analysis of regulatory mechanisms of Hox gene expression is required to better understand the genetic basis of such disease in humans.

To examine molecular mechanisms underlying the regulation of Ncx gene expression, we sequenced 5'-flanking regions of the murine and the human Ncx gene; both have a retinoic acid response element (RARE).1 Furthermore, the enhancer element necessary for tissue-specific expression was identified in the 5'-flanking region by transient transfection of the murine Ncx promoter-luciferase chimeric genes into neuroblastoma cells. The element was also conserved in the human NCX gene. We also demonstrate that nuclear proteins from neural crest-derived cells such as neuroblastoma and melanoma cells (but not from fibroblast cells) bind to the enhancer element. The regulatory region of tissue-specific expression of the Ncx gene is discussed.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Animals-- (C57BL/6 × DBA/2) F1 female mice were purchased from Japan SLC Co. Ltd. (Hamamatsu, Japan). The midday following the plugging was defined as embryonic day 0.5.

Cell Culture-- C1300 (Neuro-2A) murine neuroblastoma cells, B16 murine melanoma cells, and five kinds of human neuroblastoma cells (SH-SY5Y (15), SMS-KCN (16), SK-N-AS (17), and NBTM and GANB2) were cultured in RPMI 1640 medium (Life Technologies, Inc.) with 10% fetal calf serum (Bioserum, CSL Ltd.) at 37 °C under 5% CO2. L mouse fibroblast cells were maintained in Dulbecco's modified Eagle's medium (Life Technologies, Inc.) with 5% fetal calf serum. All-trans-retinoic acid (RA; Sigma) was dissolved in ethanol at a 10 mM concentration. RA was added to the medium in a volume corresponding to 0.1% (10 µM) of the culture medium.

Northern Blot Analysis-- Total RNAs were extracted from murine embryos and several cell lines using the Trizol reagent (Life Technologies, Inc.). Total RNAs (15 µg) were electrophoresed through a 1.0% agarose gel containing formaldehyde, transferred to a nylon membrane (Roche Molecular Biochemicals). The filter was hybridized overnight at 50 °C in 50% formamide hybridization buffer with 0.5% SDS, 1% blocking reagent, and the digoxigenin (DIG)-labeled murine Ncx homeodomain probe (193 base pairs (bp)) synthesized by polymerase chain reaction (PCR) on Ncx cDNA using primers (5'-ATCCCTACCAAAACCAAACC-3' and 5'-TTGGTGCGTCGGTTCTGGAA-3') (9). Following hybridization, the filter was washed twice for 5 min with 2× SSC and 0.1% SDS at room temperature and twice for 15 min with 0.1× SSC and 0.1% SDS at 55 °C. The DIG-labeled probe was detected with sheep anti-DIG antibody conjugated with alkaline phosphatase. The antibody detection reaction was performed using an enhanced chemiluminescent detection system (Roche Molecular Biochemicals).

Reverse Transcribed (RT)-PCR and Southern Blot Analysis-- RT-PCR and Southern blot analysis were performed as described elsewhere (9). Briefly, cDNAs were made by reverse-transcribing total RNAs (100 ng) with oligo(dT) primers and amplified 30 times with 2.5 units of Taq DNA polymerase, 2 mM MgCl2, 5% formamide, and the primers (5'-TTTGCAAAGGACAGGCTCACG-3' and 5'-GGTGCAGCAGCAGGCGACCA-3') complementary to the murine Ncx cDNA. The PCR products were separated on a 1% agarose gel and transferred onto a nylon membrane (Amersham Pharmacia Biotech). The filter was hybridized overnight with the DIG-labeled murine Ncx homeodomain probe at 42 °C. The DIG-labeled probe was detected using the same method described above.

Isolation of the Ncx Genomic Clones-- A murine Ncx genomic clone was isolated from the 129/Sv genomic library, using the murine Ncx homeodomain probe. A 10.0-kilobase pair (kb) XbaI fragment of the genomic clone was inserted into pBluescript KS(-) (Stratagene). The human NCX cDNA was isolated from the cDNA library of human neuroblastoma (SMS-KCN) cells in lambda ZAPII (Stratagene), using the murine Ncx homeodomain probe. A human NCX genomic clone was isolated from a human placenta genomic library in lambda EMBL3 (Stratagene) with the human NCX probe (a 241-bp BstXI/NotI fragment in exon 1). A 6.8-kb HindIII fragment derived from the human genomic clone was subcloned into pGEM-7Zf(+) (Promega).

Rapid Amplification of 5'-cDNA Ends (5'-RACE) Analysis-- The 5'-RACE analysis was performed using the 5'AmpliFINDER RACE kit (CLONTECH). The Ncx mRNAs in 2 µg of poly(A)+ RNA isolated from the whole body of mouse embryos at embryonic day 12.5 using oligo(dT)-cellulose columns (Life Technologies, Inc.) were reverse-transcribed using the primer 5'-AAAACGCCGCACTTTCTCC-3', complementary to nucleotides between +151 and +133 of the Ncx cDNA. The cDNA was mixed with 2.5 units of Taq DNA polymerase, 1.5 mM MgCl2, 5% formamide, the primer (5'-GGATGACTGGAAAAGGTGTTTC-3'; complementary to nucleotides between -21 and -42 of the Ncx cDNA), and the anchor primer for PCR. PCR was run for 1 min at 94 °C for denaturing, 1 min at 60 °C for annealing, and 1 min at 72 °C for extension. After 35 cycles of the PCR, the products were separated on a 1.5% agarose gel and stained with ethidium bromide. ~330-bp PCR products were ligated with pGEM-T (Promega) for sequencing.

Primer Extension-- This analysis was made using by the method described elsewhere (18). An oligonucleotide primer (5'-AGTCCGCTCTGGGACTCGCAT-3'; complementary to nucleotides between -187 and -207 of the Ncx genomic sequence) was end-labeled with [gamma -32P]ATP (Amersham Pharmacia Biotech). The labeled primer was mixed with 15 µg of poly(A)+ RNA isolated from the whole body of murine embryos at embryonic day 12.5 in 30 µl of hybridization buffer (40 mM PIPES, 1 mM EDTA, 0.4 M NaCl, 80% formamide) overnight at 30 °C. 15 µg of transfer RNA was used as a negative control. After ethanol precipitation, reverse transcription was performed at 37 °C for 1 h, and products were loaded onto a 6% sequencing gel. Nucleotide sequencing of the murine genomic Ncx gene was carried out by the dideoxy chain termination method using the same primer.

Reporter Gene Constructs-- To construct the 5'-flanking region-luciferase fusion plasmid, a 7.0-kb BssHII fragment (-7000/-73), a 3.3-kb PvuII-BssHII fragment (-3300/-73), a 1.5-kb BamHI-BssHII fragment (-1595/-73), and a 1.1-kb BstEII-BssHII fragment (-1153/-73) were isolated from the murine Ncx genomic clone and inserted into the pGL2 plasmid (Luc) carrying the SV40 enhancer and the firefly luciferase reporter gene (Promega) to generate the 7000NLuc, the 3300NLuc, the 1595NLuc, and the 1153NLuc gene, respectively. The 1492NLuc, the 1414NLuc, the 1373NLuc, the 1238NLuc, and the 1195NLuc gene were obtained by progressive exonuclease III deletion mutagenesis from the 1595NLuc plasmid with the Erase-a-base system (Promega). The 1492MLuc and the 1414MLuc gene were secured by deleting 10 bp (-1387/-1378) from the 1492NLuc and the 1414NLuc, using PCR, respectively.

Assay for the Promoter Activity with the Luciferase Reporter Gene-- 2.0 × 106 cells (C1300, B16, L, and SH-SY5Y) were plated on a 100-mm dish 1 day before transfection. The luciferase reporter plasmid (5 µg) and the sea pansy luciferase expression vector, pRL-SV40 (0.25 µg) (TOYO INK, Tokyo, Japan), as a transfection efficiency control, were co-transfected into those cells using the DNA-calcium phosphate co-precipitation technique (19). SV40Luc, the pGL2 plasmid with the SV40 promoter and enhancer and the firefly luciferase reporter gene (Promega), was used for a positive control. The transfected cells were incubated for 8 h, washed three times with phosphate-buffered saline, and further cultured with corresponding culture medium for 24 h. RA stimulation was given 8 h before harvesting. Luciferase activities in cell lysates were determined using standard methods using the pikkagene dual (TOYO INK) with luminometer (Lumat LB9507; Berthold). The firefly luciferase activity from the reporter plasmids was normalized with the sea pansy luciferase activity.

Preparation of Nuclear Extracts-- Nuclear extracts from C1300, L, B16, and SH-SY5Y cells were prepared as described elsewhere (20). Briefly, cultured cells were resuspended in hypotonic buffer. After centrifugation, nuclei were resuspended in extraction buffer and incubated on ice for 60 min. The amounts of protein in the supernatant were estimated by micro-BCA protein assay (Pierce).

Electrophoretic Mobility Shift Assay (EMSA)-- EMSA was done as described elsewhere (21). Briefly, the synthesized double-stranded oligonucleotides were labeled with DIG using the DIG Oligonucleotide 3'-End Labeling kit (Roche Molecular Biochemicals). Binding reactions were performed in a mixture containing 10 µg of nuclear proteins, 1 µg of poly(dI-dC)-poly(dI-dC) (Amersham Pharmacia Biotech), and 15 fM labeled probe in 21 µl of reaction buffer (10 mM HEPES, pH 7.8, 50 mM KCl, 1 mM dithiothreitol, 50 µg/ml bovine serum albumin). The mixture was incubated for 30 min at room temperature and separated on a 6% nondenaturing polyacrylamide gel by electrophoresis in 0.25× TBE buffer at 8 V/cm. Competitive EMSA was done by adding a 10- or 50-fold molar excess of unlabeled double-stranded oligonucleotides to the mixture. The double-stranded oligonucleotides used had the following sequences: -1387/-1368, 5'-CCTGGCCCAGTCTTACCGGC-3'; -1387/-1368 with a point mutation (m-1386), 5'-CATGGCCCAGTCTTACCGGC-3'; m-1384, 5'-CCTTGCCCAGTCTTACCGGC-3'; m-1382, 5'-CCTGGACCAGTCTTACCGGC-3'; m-1381, 5'-CCTGGCACAGTCTTACCGGC-3'; m-1380, 5'-CCTGGCCAAGTCTTACCGGC-3'; m-1379, 5'-CCTGGCCCCGTCTTACCGGC-3'; m-1378, 5'-CCTGGCCCATTCTTACCGGC-3'; m-1377, 5'-CCTGGCCCAGGCTTACCGGC-3'; m-1376, 5'-CCTGGCCCAGTATTACCGGC-3'; m-1375, 5'-CCTGGCCCAGTCGTACCGGC-3'; m-1374, 5'-CCTGGCCCAGTCTGACCGGC-3'; m-1373, 5'-CCTGGCCCAGTCTTCCCGGC-3'; m-1372, 5'-CCTGGCCCAGTCTTAACGGC-3'; m-1371, 5'-CCTGGCCCAGTCTTACAGGC-3'; m-1370, 5'-CCTGGCCCAGTCTTACCTGC-3'; m-1369, 5'-CCTGGCCCAGTCTTACCGTC-3'; m-1368, 5'-CCTGGCCCAGTCTTACCGGA-3'; and -1347/-1328, 5'-CCAGGGCCGGGGCGGGCTGG-3'.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Ncx Expression and Up-regulation with RA Stimulation in Neuronal Lineage Cells-- The Ncx gene is specifically expressed in a neuronal subset of neural crest derived tissues in murine embryos (9, 10). To further determine the cell type-specific expression, we examined the expression in several murine cell lines, using RT-PCR. The Ncx gene was expressed in C1300 neuroblastoma cells but not in B16 melanoma cells, L fibroblast cells, and M12 B lymphoma cells (Fig. 1A). We then investigated the NCX expression in several human neuroblastoma cell lines (NBTM, SH-SY5Y, SMS-KCN, SK-N-AS, and GANB), using Northern blot analysis; all expressed the NCX (Fig. 1B). PC12 rat pheochromocytoma cells also expressed the Ncx gene. (data not shown).


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 1.   Expression of Ncx mRNA. A, expression of Ncx mRNA in some murine cell lines was examined using RT-PCR and Southern blots. Expression of G3PDH (glyceraldehyde-3-phosphate dehydrogenase) mRNA is shown as a control amount of the cDNA. B, expression of NCX mRNA in human neuroblastoma cell lines was analyzed in Northern blots. An autoradiograph of a blot (top) along with a photograph (below) of the ethidium bromide-stained gel is shown. 28 and 18 S ribosomal RNAs are marked.

RA stimulation induces differentiation of some cell lines and embryonic tissues with expression of the Hox genes (22). Since RA induced morphological differentiation in C1300 and SH-SY5Y neuroblastoma cell lines (23, 24), we examined the inducibility of Ncx expression in those differentiating cells after RA stimulation. As shown in Fig. 2A, the Ncx expression was up-regulated to 10-fold of the prestimulation level in C1300 cells at 2 h and then reverted to the prestimulation level within 9 h later. In the SH-SY5Y cells, the NCX expression was also up-regulated at 6 h and then down-regulated within 24 h later (Fig. 2B).


View larger version (50K):
[in this window]
[in a new window]
 
Fig. 2.   Expression of Ncx mRNA in neuroblastoma cell lines with RA stimulation. A, Ncx expression in C1300 cells after all-trans-RA (10 mM) stimulation was examined as described above. For quantitation of the message, amounts of Ncx mRNA in 1 µg (×10), 100 ng (×1) and 10 ng (×<FR><NU>1</NU><DE>10</DE></FR>) of total RNA from pretreated C1300 cells were examined using RT-PCR. Expression of G3PDH mRNA is shown as a control amount of the cDNA. B, NCX expression in SH-SY5Y cells after all-trans-RA (10 mM) stimulation was analyzed in Northern blots. An autoradiograph of a blot (top) along with a photograph (below) of the ethidium bromide-stained gel is shown. 28 and 18 S ribosomal RNAs are marked.

Regulatory Elements in the 5'-Flanking Region of the Murine and the Human NCX Gene-- To examine the regulatory elements for cell type-specific expression and the RA responsibility of the Ncx gene, we sequenced 1597 bp of the 5'-flanking region with the translation start codon (Fig. 3) and determined the transcription initiation site of the gene by primer extension analysis and the 5'-RACE with poly(A)+ RNA from the whole body of murine embryos. Fig. 4 shows that one initiation site was located 297 bp upstream from ATG (+1). Comparison of the sequence of the 5'-RACE products to the genomic sequence confirmed that no intron existed on the 5'-flanking region from the ATG translation start codon (data not shown). When we compared the 5'-flanking sequence with established consensus sequences in a transcription factor data base, this regulatory region contained a DR2-RARE, which consists of direct repeats of two motifs (AGGTCA) separated by 2 nucleotides (25), located in the region between -1163 and -1150 and the putative binding site of Sp1 (GGGGCGGGGT; at positions -1463/-1452) and AP-1 (TGAGTCA; at positions -461/-455) (Fig. 3). However, the region lacked the conventional TATA box and the CAAT box sequence.


View larger version (60K):
[in this window]
[in a new window]
 
Fig. 3.   Nucleotide sequence of the 5'-flanking region of the murine Ncx gene. Nucleotide numbering is relative to the first nucleotide of the codon for the initiation methionine (ATG; boxed with dotted line). The transcription start site is marked with an arrow. Some restriction endonuclease sites are underlined, and the putative regulatory elements are boxed and labeled.


View larger version (57K):
[in this window]
[in a new window]
 
Fig. 4.   Primer extension analysis on the 5' end of the murine Ncx gene. The autoradiograph shows a primer extension on Ncx mRNA isolated from murine embryos (E) along with dideoxy sequencing reactions (GATC) of the murine genomic Ncx DNA. Transfer RNA (t) was used as a negative control. The same primer was used for both extension and sequencing reactions.

Since the NCX gene was also expressed and up-regulated with RA stimulation in human neuroblastoma cell lines (Fig. 2B), we sequenced 2169 bp of the 5'-flanking region from the translation start codon of the human genomic NCX gene. When the sequence was compared with that from the mouse, the regions between -1397 and -1065 (Fig. 5) and between -682 and -522 (data not shown) in the murine Ncx gene were highly conserved in the human NCX gene (-1517/-1187 and -801/-638, respectively). The region between -1517 and -1187 in the human NCX gene also contained a DR2-RARE sequence (-1283/-1270). These data suggest that these conserved regions are important for regulation of the cell type-specific expression of the Ncx gene.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 5.   Comparison of the 5'-flanking sequence of the murine Ncx gene with that of the human NCX. The 5'-flanking region of murine Ncx gene from -1397 to -1065 is highly conserved in that of human NCX gene from -1517 to -1187. Identical matches are denoted by dashes. Deleted nucleotides are indicated by asterisks. The RAREs are boxed.

Functional Analysis of the Murine Ncx Promoter-- We next analyzed a cell type-specific promoter activity in the 5'-flanking region of the murine Ncx gene by transient transfection of the promoter-reporter fusion genes into various cell lines. Various lengths of the 5'-flanking region of the Ncx gene were fused to the firefly luciferase gene. Since the endogenous Ncx was expressed in SH-SY5Y and C1300 cells but not in B16 and L cells (Fig. 1), those chimeric constructs were transfected into those four cell lines to examine the cell type-specific promoter activity (Fig. 6A). A significant increase (3-8-fold) of the luciferase activity was observed in all four cell lines when the 1153NLuc gene was transfected, suggesting the presence of a minimal promoter element in the first 856 bp (-1153/-297) of this 5'-flanking region. When the 1595NLuc construct was transfected into SH-SY5Y and C1300 cells, the luciferase activity increased about 10-fold over the activity observed in the case of 1153NLuc transfection. However, this augmentation was not detected in B16 and L cells transfected with the 1595NLuc gene. Transfection of the 3300NLuc and the 7000NLuc construct demonstrated almost the same activity as that of the 1595NLuc, in all cell lines tested. These results suggested that the region between -1595 and -1153 is important for cell type-specific expression of the Ncx gene.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 6.   Murine Ncx promoter-reporter constructs and their relative luciferase activity. A, left, schematic representation of the reporter gene constructs 7000NLuc, 3300NLuc, 1595NLuc, 1153NLuc, and Luc obtained by deletions of the 5' region of the Ncx gene and SVLuc as a positive control. Right, luciferase activity observed in SH-SY5Y (hatched bars), C1300 (stippled bars), B16 (closed bars), and L cells (open bars) transfected with the different reporter genes. B, left, schematic representation of the reporter gene constructs 1595NLuc, 1492NLuc, 1414NLuc, 1373NLuc, 1238NLuc, 1195NLuc, 1153NLuc. RARE (open circles) and Sp1 (closed circles) on the 5'-flanking region of the Ncx gene are indicated. Right, luciferase activity observed in C1300 (stippled bars). The values are the means of triplicate experiments from three independent studies. All values are a percentage of activity of the construct Luc (1%), in respective cell lines.

To further characterize the regulatory region of the murine Ncx gene, a series of deletion clones from the region between -1595 and -1153, prepared using the Erase-a-base system and fused to the luciferase reporter gene, were transfected into C1300 cells (Fig. 6B). The region between -1373 and -1153 did not enhance the promoter activity, irrespective of the presence of RARE. The promoter activity of the constructs with the region between -1414 and -1153 was more than 7-fold higher than that with the region between -1373 and -1153. These findings suggest that the region between -1414 and -1374 plays an important role in determining enhancer activity in neuroblastoma cells of the Ncx gene.

A DNA Element for the Cell Type-specific Expression in the 5'-Flanking Region of the Murine Ncx Gene-- The reporter gene analysis using a series of deletion clones in the 5'-flanking region indicated that a DNA element regulating the cell type-specific transcription of the Ncx gene was located in the region between -1414 and -1374. Furthermore, the DNA sequence of the region between -1397 and -1065 in the murine Ncx gene was highly conserved in the human NCX gene. These observations strongly suggested that nuclear factors derived from neuroblastoma cells bound to the region between -1397 and -1374 to regulate cell type-specific expression of the Ncx gene. To examine this possibility, we synthesized three kinds of double-stranded oligonucleotides (-1397/-1358, -1387/-1368, and -1377/-1338) that span this region and did EMSA experiments with nuclear proteins from C1300, L, B16, and SH-SY5Y cells. A specific band was detected in nuclear proteins from C1300, SH-SY5Y, and B16 but not in proteins of L cells when the -1387/-1368 oligonucleotides were used (Fig. 7). This binding was inhibited with unlabeled -1387/-1368 oligonucleotides but not with the unlabeled -1347/-1328 oligonucleotides in C1300 murine neuroblastoma cells (Fig. 8), suggesting that nuclear factors bind to the DNA region between -1387 and -1368. In order to delineate the binding site within the 20-bp element, we tested a series of mutations in EMSA competition experiments. Unlabeled oligonucleotides with a mutation at -1384 or -1373 could not inhibit the binding, although oligonucleotides with a mutation at other sites could do so. Similar results were obtained using nuclear proteins from SH-SY5Y human neuroblastoma cells (data not shown). Therefore, the DNA element between -1387 and -1368 controls the cell type-specific expression of the Ncx, and nuclear factors that bind to this element are present in cell lines derived from neural crest tissues in mouse and human.


View larger version (50K):
[in this window]
[in a new window]
 
Fig. 7.   EMSA of nuclear proteins interacting with the DNA region between -1387 and -1368 of the murine Ncx sequence. The labeled oligonucleotide (-1387/-1368) probe was incubated with 10 µg of nuclear extracts from B16, L cell, C1300, or SH-SY5Y.


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 8.   EMSA with various mutated oligonucleotides as a competitor. A, the labeled oligonucleotide (-1387/-1368) probe was incubated with 10 µg of nuclear extracts from C1300 murine neuroblastoma cell lines with various competitors. For competition, 10-fold (+) or 50-fold (++) molar excess of the unlabeled oligonucleotide -1387/-1368 or -1347/-1328 or mutated oligonucleotides were used. -1387/-1368-specific DNA-protein complexes are indicated by arrows. B, a sequence of the 20-bp element in mice and humans. Critical nucleotides for factor binding are underlined.

Next we examined effects of this element on Ncx promoter activity by preparing deletion mutants of the reporter plasmids. Deletion from -1387 to -1368 was introduced to the 1492NLuc and the 1414NLuc reporter plasmid (1492MLuc and 1414MLuc, respectively), and the promoter activity of those plasmids in C1300 neuroblastoma cells was measured. When the 1492MLuc or the 1414MLuc reporter plasmid was transfected, luciferase activity dramatically decreased to <FR><NU>1</NU><DE>5</DE></FR>-<FR><NU>1</NU><DE>8</DE></FR>-fold compared with the case of wild type reporter plasmids (Fig. 9). These results also confirm that the DNA element from -1387 to -1368 is required for display of the proper expression level of the Ncx gene in neural crest-derived cells.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 9.   Murine Ncx promoter-reporter constructs with deletion of a part of the enhancer element (-1387/-1368) and their relative luciferase activity. Left, schematic representation of the reporter gene constructs 1492NLuc, 1492MLuc, 1414NLuc, 1414MLuc, and 1373NLuc. Right, luciferase activity observed in C1300 transfected with different reporter genes. The values are means of triplicate experiments from three independent studies.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Expression of the Ncx gene is tightly regulated in neuronal lineage of neural crest-derived tissues (9, 10). We confirmed the tissue-specific expression of Ncx in various cell lines, using a sensitive RT-PCR assay. This gene was expressed in neuronal cells derived from the neural crest such as neuroblastoma cell lines but not in fibroblast and B lymphoma cells. Although melanocytes are derived from the neural crest (11), the expression was never detected in B16 murine melanoma cells. Therefore, we attempted to identify the regulatory region governing the tissue-specific expression in the 5'-flanking region of the Ncx gene, and for this we transfected promoter-reporter fusion genes into those cell lines. First, we sequenced 5'-flanking regions of the murine and the human Ncx gene. Neither the TATA box nor the CAAT box consensus sequence was identified in the 5'-flanking regions of murine and human Ncx genes. The promoter regions of Hoxa-4 (26), Hoxb-4 (27), Hoxc-4 (28), Hoxc-6 (29), and Hoxc-8 (30) also lack the TATA box. Transient transfection experiments (Fig. 6A) suggest that the minimal promoter element of the murine Ncx gene locates in the region between -1153 and -73. The regions between -1153 and -1065 and between -682 and -522 in the Ncx gene were highly conserved in humans (data not shown), suggesting a presence of the common basic regulatory element in those regions. However, none of the known consensus sequence was found in those regions.

Second, we found that the region between -1414 and -1373 of the murine Ncx gene plays an important role in determining its cell type-specific expression (Fig. 6B). Furthermore, we found that a putative nuclear factor specifically bound to the region between -1387 and -1368, as determined by EMSA (Fig. 7), and nucleotides at the position -1384 or -1373 are critical for the binding. The sequence of this region, highly conserved between murine and human, does not resemble any known consensus bindng sequence of transcription factors by data base search. This factor was detected in nuclear proteins from not only murine and human neuroblastoma cell lines but also the B16 melanoma cell line. However, it was not detected in nuclear proteins from L fibroblast cells. Therefore, the DNA region between -1387 and -1368 may be the element for determining the neural crest tissue-specific expression of Ncx. Since the promoter activity was only enhanced in neuroblastoma cells and not in the B16 melanoma cell line, additional nuclear factors specific to the neuronal lineage cells are required to control lineage-restricted expression of the Ncx gene of neural crest-derived cells. Further characterization of this factor may reveal not only the molecular mechanism of tissue-specific expression of the Ncx gene but also mechanisms related to lineage commitment of neural crest to neuronal cells.

Ncx expression was augmented in C1300 or SH-SY5Y cells with RA stimulation. The 5'-flanking regions of the human and the murine Ncx gene carried the DR2-RARE. When C1300 cells were transfected with the 1298NLuc construct containing RARE and stimulated with RA to examine the inducibility, the luciferase activity with RA stimulation was up-regulated 3-fold above that without RA stimulation (data not shown), suggesting that this RARE is functional. Several Hox genes also have RARE in their noncoding region (31). For example, the 3'-flanking sequence of the Hoxa-1 gene has the DR5-RARE, the direct repeats separated by 5 nucleotides, that regulate its expression (32). The Hoxb-1 gene has two DR2-RAREs, which locate in the 5'- and 3'-flanking regions. RARE in the 3'-flanking region functions as a tissue-specific enhancer. Point mutation of RARE in the 3' side prevented the neuronal expression of Hoxb-1 in transgenic mice (33). On the other hand, RARE in the 5'-flanking region is an essential component of the repressor element to refine the Hoxb-1 expression to hind brain (34). Thus, those two RAREs control the tissue-specific expression of the Hoxb-1 gene. Although RARE in the 5'-flanking region of the Ncx gene is functional in neuroblastoma cells (Fig. 2), RARE is not essential for the cell type-specific expression of the Ncx gene in vitro (Fig. 6B). Further in vivo studies using transgenic mice should reveal the precise function of this RARE element.

RA is known to induce differentiation in some neuroblastoma cell lines. Both C1300 and SH-SY5Y underwent morphological changes upon stimulation with RA, and expression of Ncx was up-regulated in these cells after the stimulation. To examine the relation between the expression of Ncx and neuronal differentiation, differentiation was induced in neuroblastoma cell lines by various stimuli other than RA. C1300 cells are known to differentiate after serum deprivation (35). However, Ncx expression in C1300 cells was not induced after serum deprivation; rather, it was down-regulated (data not shown). SH-SY5Y cells differentiate upon nerve growth factor stimulation (36). During the differentiation after nerve growth factor stimulation, the amount of the NCX message remained unchanged (data not shown). Moreover, the Ncx-deficient mice showed normal differentiation of neural crest-derived neurons such as dorsal root ganglia, trigeminus ganglia, and enteric ganglia (10, 14). Therefore, Ncx is not directly related to neuronal differentiation and may not be essential for differentiation of neural crest lineage cells.

Several transcriptional factors important for differentiation of neural crest have been identified, and most act as a master gene for lineage determination of neural crest cells. The Mash1 (mammalian achaete-scute homologue 1) gene, encoding basic helix-loop-helix transcription factor, is expressed only in precursors of all autonomic neurons, not in those of sensory neurons (37). A targeted mutation in Mash1 blocks the development of sympathetic, parasympathetic, and a subset of enteric neurons (38), indicating that this gene product plays a critical role in autonomic neurogenesis. The Neurogenin 1 (39) and the neurogenin 2 (also known as Math4A) (40), expressed in sensory but not in autonomic ganglia, are thought to be important for lineage determination of sensory cells. The Ncx gene is expressed in all of the neuronal lineage derived from neural crest (9). Data presented here demonstrate that the DNA element (between -1387 and -1368) located in the 5'-flanking region of the Ncx gene is critical for enhancer activity in neuroblastoma cells. In Ncx-deficient mice, megacolon, which occurs with an increased number of enteric neurons, resembles neuronal intestinal dysplasia, a disease in humans (10, 14). Further characterization of a regulatory mechanism of tissue-specific expression of Ncx should reveal a genetic basis of this disease.

    ACKNOWLEDGEMENTS

We are grateful to Dr. T. Matsumura for the gift of C1300 cell lines and Dr. A. Nakagawara for helpful discussion and for providing the five human neuroblastoma cell lines. We also thank H. Satake for skillful technical assistance, N. Fujita for secretarial assistance, and M. Ohara for comments on the manuscript.

    FOOTNOTES

* This work was supported by a grant-in-aid for scientific research on priority areas from the Ministry of Education, Science, Sports and Culture, Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AB008500 (the 5'-flanking region of the murine Ncx), AB008501 (the human NCX cDNA), and AB008502 (the 5'-flanking region of the human NCX).

To whom correspondence should be addressed: Dept. of Developmental Genetics, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. Tel.: 81-43-226-2182; Fax: 81-43-226-2183; E-mail: hatano@med.m.chiba-u.ac.jp.

2 Y. Iitsuka, H. Shimizu, M. M. Kang, K. Sasagawa, S. Sekiya, T. Tokuhisa, and M. Hatano, unpublished data.

    ABBREVIATIONS

The abbreviations used are: RARE, retinoic acid response element; RA retinoic acid, DIG, digoxigenin; bp, base pair(s); PCR, polymerase chain reaction; RT-PCR, reverse transcribed polymerase chain reaction; kb, kilobase pair(s); 5'-RACE, rapid amplification of 5'-cDNA ends; EMSA, electrophoretic mobility shift assay.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Krumlauf, R. (1994) Cell 78, 191-201[CrossRef][Medline] [Order article via Infotrieve]
2. Dear, T. N., Sanchez-Garcia, I., and Rabbitts, T. H. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 4431-4435[Abstract/Free Full Text]
3. Raju, K., Tang, S., Dubé, I. D., Kamel-Reid, S., Bryce, D. M., and Breitman, M. L. (1993) Mech. Dev. 44, 51-64[CrossRef][Medline] [Order article via Infotrieve]
4. Dubé, I. D., Kamel-Reid, S., Yuan, C. C., Lu, M., Wu, X., Corpus, G., Raimondi, S. C., Crist, W. M., Carroll, A. J., Minowada, J., and Baker, J. B. (1991) Blood 78, 2996-3003[Abstract/Free Full Text]
5. Hatano, M., Roberts, C. W., Minden, M., Crist, W. M., and Korsmeyer, S. J. (1991) Science 253, 79-82[Abstract/Free Full Text]
6. Kennedy, M. A., Gonzalez-Sarmiento, R., Kees, U. R., Lampert, F., Dear, N., Boehm, T., and Rabbitts, T. H. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 8900-8904[Abstract/Free Full Text]
7. Lu, M., Gong, Z. Y., Shen, W. F., and Ho, A. D. (1991) EMBO J. 10, 2905-2910[Medline] [Order article via Infotrieve]
8. Wen, X. Y., Tang, S., and Breitman, M. L. (1994) Genomics 24, 388-390[CrossRef][Medline] [Order article via Infotrieve]
9. Hatano, M., Iitsuka, Y., Yamamoto, H., Dezawa, M., Yusa, S., Kohno, Y., and Tokuhisa, T. (1997) Anat. Embryol. 195, 419-425[CrossRef][Medline] [Order article via Infotrieve]
10. Shirasawa, S., Yunker, A. M., Roth, K. A., Brown, G. A., Horning, S., and Korsmeyer, S. J. (1997) Nat. Med. 3, 646-650[CrossRef][Medline] [Order article via Infotrieve]
11. Selleck, M. A., Scherson, T. Y., and Bronner-Fraser, M. (1993) Dev. Biol. 159, 1-11[CrossRef][Medline] [Order article via Infotrieve]
12. Kamps, M. P., Murre, C., Sun, X. H., and Baltimore, D. (1990) Cell 60, 547-555[CrossRef][Medline] [Order article via Infotrieve]
13. Nourse, J., Mellentin, J. D., Galili, N., Wilkinson, J., Stanbridge, E., Smith, S. D., and Cleary, M. L. (1990) Cell 60, 535-545[CrossRef][Medline] [Order article via Infotrieve]
14. Hatano, M., Aoki, T., Dezawa, M., Yusa, S., Iitsuka, Y., Koseki, H., Taniguchi, M., and Tokuhisa, T. (1997) J. Clin. Invest. 100, 795-801[Medline] [Order article via Infotrieve]
15. Hammerling, U., Bjelfman, C., and Pahlman, S. (1987) Oncogene 2, 73-77[Medline] [Order article via Infotrieve]
16. Nakagawara, A., Azar, C. G., Scavarda, N. J., and Brodeur, G. M. (1994) Mol. Cell. Biol. 14, 759-767[Abstract/Free Full Text]
17. Cohen, P. S., Letterio, J. J., Gaetano, C., Chan, J., Matsumoto, K., Sporn, M. B., and Thiele, C. J. (1995) Cancer Res. 55, 2380-2386[Abstract/Free Full Text]
18. Arai, Y., Hatano, M., and Tokuhisa, T. (1997) Gene (Amst.) 193, 73-79[CrossRef][Medline] [Order article via Infotrieve]
19. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , p. 16.32, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
20. Ochi, Y., Koizumi, T., Kobayashi, S., Phuchareon, J., Hatano, M., Takada, M., Tomita, Y., and Tokuhisa, T. (1994) J. Immunol. 153, 3485-3490[Abstract]
21. Yoshida, T., Fukuda, T., Okabe, S., Hatano, M., Miki, T., Hirosawa, S., Miyasaka, N., Isono, K., and Tokuhisa, T. (1996) Biochem. Biophys. Res. Commun. 228, 216-220[CrossRef][Medline] [Order article via Infotrieve]
22. Marshall, H., Morrison, A., Studer, M., Popperl, H., and Krumlauf, R. (1996) FASEB J. 10, 969-978[Abstract]
23. Riboni, L., Prinetti, A., Bassi, R., Caminiti, A., and Tettamanti, G. (1995) J. Biol. Chem. 270, 26868-26875[Abstract/Free Full Text]
24. Pahlman, S., Ruusala, A. I., Abrahamsson, L., Mattsson, M. E., and Esscher, T. (1984) Cell Differ. 14, 135-144[CrossRef][Medline] [Order article via Infotrieve]
25. Durand, B., Saunders, M., Leroy, P., Leid, M., and Chambon, P. (1992) Cell 71, 73-85[CrossRef][Medline] [Order article via Infotrieve]
26. Galliot, B., Dolle, P., Vigneron, M., Featherstone, M. S., Baron, A., and Duboule, D. (1989) Development 107, 343-359[Abstract]
27. Gutman, A., Gilthorpe, J., and Rigby, P. W. (1994) Mol. Cell. Biol. 14, 8143-8154[Abstract/Free Full Text]
28. Geada, A. M., Gaunt, S. J., Azzawi, M., Shimeld, S. M., Pearce, J., and Sharpe, P. T. (1992) Development 116, 497-506[Medline] [Order article via Infotrieve]
29. Coletta, P. L., Shimeld, S. M., Chaudhuri, C., Muller, U., Clarke, J. P., and Sharpe, P. T. (1991) Mech. Dev. 35, 129-142[CrossRef][Medline] [Order article via Infotrieve]
30. Awgulewitsch, A., Bieberich, C., Bogarad, L., Shashikant, C., and Ruddle, F. H. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 6428-6432[Abstract/Free Full Text]
31. De Luca, L. M. (1991) FASEB J. 5, 2924-2933[Abstract]
32. Langston, A. W., and Gudas, L. J. (1992) Mech. Dev. 38, 217-227[CrossRef][Medline] [Order article via Infotrieve]
33. Marshall, H., Studer, M., Popperl, H., Aparicio, S., Kuroiwa, A., Brenner, S., and Krumlauf, R. (1994) Nature 370, 567-571[CrossRef][Medline] [Order article via Infotrieve]
34. Studer, M., Popperl, H., Marshall, H., Kuroiwa, A., and Krumlauf, R. (1994) Science 265, 1728-1732[Abstract/Free Full Text]
35. Maltese, W. A., Reitz, B. A., and Volpe, J. J. (1981) J. Cell. Physiol. 108, 475-482[CrossRef][Medline] [Order article via Infotrieve]
36. Sonnenfeld, K. H., and Ishii, D. N. (1982) J. Neurosci. Res. 8, 375-391[CrossRef][Medline] [Order article via Infotrieve]
37. Lo, L. C., Johnson, J. E., Wuenschell, C. W., Saito, T., and Anderson, D. J. (1991) Genes Dev. 5, 1524-1537[Abstract/Free Full Text]
38. Guillemot, F., Lo, L. C., Johnson, J. E., Auerbach, A., Anderson, D. J., and Joyner, A. L. (1993) Cell 75, 463-476[CrossRef][Medline] [Order article via Infotrieve]
39. Ma, Q., Kintner, C., and Anderson, D. J. (1996) Cell 87, 43-52[CrossRef][Medline] [Order article via Infotrieve]
40. Sommer, L., Ma, Q., and Anderson, D. J. (1996) J. Mol. Cell. Neurosci. 8, 221-241


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iitsuka, Y.
Right arrow Articles by Hatano, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iitsuka, Y.
Right arrow Articles by Hatano, M.
Social Bookmarking
 Add to CiteULike